Log in to your IBTimes Account

close
ID
Password

Thomas & Betts shares rose after Leviton sale



By DAN STRUMPF, AP
25 June 2008 @ 12:35 pm EST

NEW YORK - Shares of Thomas & Betts Corp. jumped on Wednesday after the maker of electrical components said it has sold its stake in Leviton Manufacturing Co. for $300 million.

Related Topic

Get stories by e-mail on this topic.

E-mail:

Shares advanced $1.65, or 4.4 percent, to $39.32 in midday trading.

RBC Capital Markets analyst Amit Daryanani said the sale resolves a long-standing distraction for Thomas & Betts and should focus investor attention back to its core business.

Daryanani said the company's issues with Leviton date back to 2002, when Thomas & Betts said it had lost its influence at Leviton. He said the sale should give shares a boost.

Thomas & Betts spokeswoman Tricia Bergeron said that a change in Thomas & Betts's management in 2002 led to the loss of influence at Leviton and a change in accounting practices for its stake in the company.

She said Thomas & Betts sold its stake in Leviton not because of personal differences between the two companies, but because it is "in the best interest of our shareholders."

Daryanani maintained an "Outperform" rating on Thomas & Betts and $45 price target on the Memphis, Tenn., company.

Oppenheimer's Christopher Glynn also praised the sale. He called Thomas & Betts a "top pick" and reiterated his "Outperform" rating on the company.

Thomas & Betts said in a release after the close of trading Tuesday it was selling its 29.1 percent stake back to privately held Leviton and predicted the sale would add $1.70 per share to its second-quarter earnings.

Shares of Thomas & Betts have traded between $33.26 and $64.28 in the last 52 weeks.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

You must be an IBTimes member to post a comment. Login | Register


advertisement
More Industries
Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems In...
With the economy crumbling and revenues plunging, Atlantic City is considering delaying the start of a total smoking ban at its 11 casinos. The ban, whic...
Shares of chemicals maker DuPont Co. hit a two-year low Monday amid investor worries that the U.S. government's financial bailout would do little to unfr...

Advertisement
Corporate Website Design

Professional Website Design For Corporate - Get a Free Quote Today

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives